Scott Henry
Stock Analyst at Alliance Global Partners
(1.25)
# 3,687
Out of 5,112 analysts
51
Total ratings
37.74%
Success rate
-5.32%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.07 | +180.37% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.22 | +207.38% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.98 | +203.03% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $4.20 | +138.10% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.71 | +286.34% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.92 | +7.32% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.90 | +344.44% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $3.32 | +351.81% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.58 | +1,951.98% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $7.22 | +3.88% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.93 | +30.92% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $33.95 | -29.31% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $23.67 | -34.52% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $85.27 | -31.98% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $96.34 | -62.63% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.97 | +1,034.02% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.84 | +56.25% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $1.29 | +445,636.43% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.59 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.90 | +676.91% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.21 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.95 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.22
Upside: +207.38%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.98
Upside: +203.03%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $4.20
Upside: +138.10%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.71
Upside: +286.34%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.92
Upside: +7.32%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.90
Upside: +344.44%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $3.32
Upside: +351.81%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.58
Upside: +1,951.98%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $7.22
Upside: +3.88%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.93
Upside: +30.92%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $33.95
Upside: -29.31%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $23.67
Upside: -34.52%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $85.27
Upside: -31.98%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $96.34
Upside: -62.63%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $0.97
Upside: +1,034.02%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.84
Upside: +56.25%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $1.29
Upside: +445,636.43%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.90
Upside: +676.91%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $18.21
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.95
Upside: -